Exagen (XGN) Other Operating Expenses (2018 - 2023)

Exagen (XGN) has 6 years of Other Operating Expenses data on file, last reported at -$17.5 million in Q4 2023.

• Quarterly Other Operating Expenses fell 247.88% year-over-year to -$17.5 million in Q4 2023, while the trailing twelve-month figure through Sep 2024 was -$17.5 million (down 159.66% YoY) and the FY2022 annual result came in at $29.7 million, up 44.36% from the prior year.
• Other Operating Expenses eased to -$17.5 million in Q4 2023, from $5.7 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $11.8 million in Q4 2022 to a low of -$17.5 million in Q4 2023.
• A 5-year average of $4.3 million and a median of $5.0 million in 2019 frame the typical range for Other Operating Expenses.
• Annual changes were most pronounced in 2022 — Other Operating Expenses jumped 139.22% — and 2023, when it tumbled 247.88%.
• Tracing XGN's Other Operating Expenses over 5 years: stood at $4.6 million in 2019, then dropped by 5.58% to $4.3 million in 2020, then grew by 13.93% to $4.9 million in 2021, then surged by 139.22% to $11.8 million in 2022, then plunged by 247.88% to -$17.5 million in 2023.
• The last three Other Operating Expenses figures came in at -$17.5 million (Q4 2023), $5.7 million (Q3 2023), and $5.8 million (Q2 2023), per Business Quant data.